Janssen-Cilag, S.A.
20 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives (NCT04476446) | Janssen-Cilag, S.A. | 2020-09-08 |
| Treatment Resistant Depression in America Latina (NCT03207282) | Janssen-Cilag, S.A. | 2017-09-27 |
Track Janssen-Cilag, S.A. automatically
Every clearance here is in the API, with alerts when new ones post.